HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Cancer is a complex and multifaceted disease, with its roots deeply embedded in both genetics and epigenetics. The study of cancer genetics focuses on understanding how alterations in the DNA sequence contribute to the development and progression of cancer. Genetic mutations can lead to the uncontrolled growth of cells, a hallmark of cancer. Epigenetics, on the other hand, explores changes in gene expression that do not involve alterations to the underlying DNA sequence. These modifications can be influenced by environmental factors and lifestyle choices, impacting the way genes are turned on or off. In cancer, aberrant epigenetic changes can contribute to the dysregulation of normal cellular processes. The interplay between genetics and epigenetics in cancer is intricate. Genetic mutations can drive epigenetic changes, and vice versa, creating a feedback loop that sustains the malignant transformation of cells. Both factors contribute to the heterogeneity observed in different cancer types and among individual patients. Understanding the molecular intricacies of cancer genetics and epigenetics is crucial for developing targeted therapies. Precision medicine aims to tailor treatments based on the specific genetic and epigenetic profile of each patient's cancer. This approach holds promise for more effective and personalized cancer treatments, ultimately improving patient outcomes. Researchers continue to unravel the complexities of cancer at the genetic and epigenetic levels, providing insights that pave the way for innovative therapeutic strategies. As our understanding deepens, the potential for breakthroughs in cancer prevention, diagnosis, and treatment becomes increasingly tangible.
